Acciones Aegerion Pharmaceuticals, Inc.

Acciones

Diferido Nasdaq Otros sitios de cotización 22:00:00 29/11/2016			Varia. Cinco días.	Varia. 1 de enero.
1,97 ^USD	+5,35 %		+4,23 %	-80,50 %

Duración

Período

Estilo

Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc.	29/11/16
Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) Receives Pricing Authorization in Japan	17/11/16
Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results	03/11/16
Aegerion Pharmaceuticals : Research Reports Coverage on Biotech Stocks -- Merrimack Pharma, Aurinia Pharma, Aegerion Pharma, and TG Therapeutics	24/10/16
Aegerion Pharmaceuticals' : JUXTAPID® (lomitapide) Capsules Approved in Japan for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)	28/09/16

1 día

+5,35 %

Directores	Puesto	Edad	Desde
Sheila Frame PSD	President	62	-
Elizabeth Jobes BRD	Director/Board Member	57	-
Ailish Hogan SEC	Corporate Secretary	-	-

Administradores	Puesto	Edad	Desde
Sheila Frame PSD	President	62	-
Elizabeth Jobes BRD	Director/Board Member	57	-

Sector